Evaluation of the role of the severe hyperparathyroidism on corony artery calcification in dialysis patients

Clinical Nephrology

Volumn 67, Issue 2, 2007, Pages 89-95

  Hernandes, F R ^a,b   Barreto, F C ^a   Rocha, L A ^a   Draibe, S A ^a   Canziani, M E F ^a   Carvalho, A B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Calcification; Dialysis; Hyperparathyroidism; Kidney failure; Osteoprotegerin

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; CALCIUM ION; CALCIUM PHOSPHATE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; LOW DENSITY LIPOPROTEIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHORUS; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERY CALCIFICATION; ARTICLE; BLOOD SAMPLING; BONE DENSITOMETRY; BONE DENSITY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FEMUR NECK; HUMAN; LUMBAR VERTEBRA; MALE; MINERAL METABOLISM; MORTALITY; PARATHYROIDECTOMY; PREVALENCE; RENAL REPLACEMENT THERAPY; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; UNIVARIATE ANALYSIS;

EID: 33847280939     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp67089     Document Type: Article

References (43)

1. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte MJr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990; 15: 827-832.
2. Ahmed S, O'Neill KD, Hood AF Evan AP, Moe SM. Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis. 2001; 37: 1267-1276.
3. Arad Y, Spadaro LA, Roth M, Scordo J, Goodman K, Sherman S, Lerner G, Newstein D, Guerci AD. Serum concentrations of calcium, 1,25-vitamin D and parathyroid hormone are not correlated with coronary calcifications: An electron beam computed tomography study. Coron Artery Dis. 1998; 9: 513-518.
4. Barreto DV, Barreto FC, Carvalho AB, Cuppari L, Cendoroglo M, Draibe SA, Moyses RMA, Neves KR, Jorgetti V, Blair A, Guiberteau R, Canziani MEF. Coronary calcification in hemodialysis patients: The contribution of traditional and uremia-related risk factors. Kidney Int. 2005; 67: 1576-1582.
5. Barreto FC, Barreto DV, Moysés RMA, Neves CL, Jorgetti V, Draibe SA, Canziani MEF, Carvalho AB. Osteoporosis in hemodialysis patients revisited by bone histomorphometry. A new insight into an old problem. Kidney Int. 2006; 69: 1852-1857.
6. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001; 38: 938-942.
7. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis. 1998; 31: 607-617.
8. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis. 2000; 35: 1226-1237.
9. Block GA. Prevalence and clinical consequences of elevated Ca × P product in hemodialysis patients. Clin Nephrol. 2000; 54: 318-324.
10. Bloembergen WE. Cardiac disease in chronic uremia: Epidemiology. Adv Ren Replace Ther. 1997; 4: 185-193.
11. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft F. Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients. Am J Kidney Dis. 1996; 27: 395-401.
12. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan H, Xu W, Lacey D, Boyle W, Simonet W. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998; 12: 1260-1268.
13. Canavese C, Cesarani F, Stratta C, Maddalena E, Messina M, Hamido D, Bianchi DS, Segoloni GP. Dramatic worsening of vascular calcifications after kidney transplantation in spite of early parathyroidectomy. Clin Nephrol. 2000; 54: 487-491.
14. Coen G, Ballanti P, Balducci A, Calabria S, Fischer MS, Jankovic L, Manni M, Morosetti M, Moscaritolo E, Sardella D, Bonucci E. Serum osteoprotegerin and renal osteodystrophy. Nephrol Dial Transplant. 2002; 17: 233-238.
15. Foley RN, Parfrey OS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32: 112-119.
16. Ganesh SK, Stack AG, Levin NW, Hubert-Shearon T, Port FK. Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Neprol. 2001; 12: 2131-2138.
17. Goodman WG, Goldin J, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000; 342: 1478-1483.
18. Guérin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcification in end-stage renal disease. Nephrol Dial Transplant. 2000; 15: 1014-1021.
19. Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, Nissenson RA. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res. 2004; 19: 235-244.
20. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res.. 2000; 87: E10-17.
21. Jono S, Ikari Y, Shioi A, Mori K, Niki T, Hara K, Nishizawa Y. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation. 2002; 106: 1192-1194.
22. K/DOQI. Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis. 2003; 42 (Suppl 3): 76-77.
23. Khosla S. Minireview: OPG/RANK/RANKL system. Endocrinology. 2001; 142: 5050-5055.
24. Lobão R, Carvalho AB, Cuppari L, Ventura R, Lazaretti-Castro M, Jorgetti V, Heira JG, Cendoroglo M and Draibe AS. High prevalence of low bone mineral density in pre-dialysis chronic kidney disease patients: bone histomorphometric analysis. Clin Nephrol. 2004; 62: 432-439.
25. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003; 18: 1731-1740.
26. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, Vernejoul MC. Arterial Calcifications and Bone Histomorphometry in End-Stage Renal Disease. J Am Soc Nephrol. 2004; 15: 1943-1951.
27. London GM. Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J Am Soc Nephrol. 2003; 14 (Suppl 4): 305-309.
28. Marco MP, Craver L, Bertriu A, Berlat M, Fibla J, Fernandez E. Higher impact of mineral matabolism on cardiovascular mortality in a European hemodialysis population. Kidney Int. 2003; 85 (Suppl): S111-S119.
29. Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, Takishita S. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol. 2004; 8: 54-58.
30. Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki S, Gomibuchi T, Yano K, Shima N, Washida N, Tsuda E, Morinaga T, Higashio K, Ozawa H. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun. 1998; 247: 610-615.
31. Nitta K, Akiba T, Uchida K, Kawashima A, Ymura W, Kabaya T, Nihei H. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis. 2003; 42: 303-309.
32. Oniya JE, Miles RR, Yang X, Halladay DL, Hale J, Glasebrook A, McClure D, Seno G, Churgay L, Chandrasekhar S, Matin TJ. in vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. J Bone Miner Res. 2000; 25: 863-871.
33. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002; 39: 695-701.
34. Ribeiro S, Ramos A, Brandao A, Rebelo JR, Guerra A, Resina C, Vila-Lobos A, Carvalho F, Remédio F, Ribeiro F. Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism. Nephrol Dial Transplant. 1998; 13: 2037-2040.
35. Rumberger JA, Brundage BH, Rader DJ, Kondos G. Electron beam computed tomography coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc. 1999; 74: 243-252.
36. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcification area by electron-bean computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation. 1995; 92: 2157-2162.
37. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Naguyen HO, Wooden S, Bennett L, Boone T, Shimammoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Geee, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell. 1997; 89: 309-319.
38. Stompor T, Pasowicz M, Sullowicz W, Dembinska-Kiec A, Janda K, Wojcik K, Tracsz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis. 2003; 41: 203-211.
39. Tanko LB, Bagger YZ, Christiansen C. Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int. 2003; 73: 15-20.
40. Valderrabano F, Jones EH, Mallick NP. Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant. 1995; 10 (Suppl 5): 1-25.
41. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study. J Am Soc Nephrol. 2003; 14: 159-168.
42. Yun TJ, Chaudhary PM, Shu GL, Frazer JK, Ewings MK, Schwartz SM, Pascual V, Hood LE, Clark EA. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol. 1998; 161: 6113-6121.
43. Zoccalli C. Cardiovascular risk in uraemic patients - Is it fully explained by classical risk factors? Nephrol Dial Transplant. 2000; 15: 454-457.